Tackling Antimicrobial Resistance (AMR) Globally By 2030, the

Tackling Antimicrobial Resistance (AMR)
Globally
By 2030, the global human consumption of antibiotics is forecast to rise by more than 30% (up to 200% if it
continues growing at current rates)
New generation of superbugs that cant be treated with existing medicines
Few replacement or alternative products in the development pipeline
At least 700,000 deaths around the world each year. Predicted to rise to 10million, alongside a cumulative cost
of $100trillion, by 2050 if no action is taken

Nationally
2013-2018 strategy and UK Government
ambitions on AMR have helped reduce antibiotic
use in both humans and food-producing animals.
Drug resistant infections in humans continues to
increase. Increase in absolute numbers of E.coli
blood stream infections that are resistant to one or
more drugs

Locally
Variation in provider CQUINs

Work to date
Kent Surrey and Sussex Antimicrobial
group
CCG Collaborative Working Group
- Joint Antibiotic Awareness Week (AAW) &
Antibiotic Guardian (AG) presentation
- Data presentation to Area Prescribing
Committee

Variation in Primary Care Quality Premiums

Workplan
Surrey Heartlands joint infection control and AMR
multidisciplinary group
Promotion and implementation of Public Health
England guidelines for primary care
Standardisation of secondary care prescribing
guidelines
Cross sector programme for AAW and AG
Agreed approach for monitoring and supporting action
for CQUINs and QPs

Future ambitions
Education in schools food hygiene & antibiotics
Specialist workforce right expert in the right place at the right time
Electronic prescribing supporting AMR

Contact Details: [email protected]
or [email protected]

Presented at the NHS England Integrating Pharmacy and Medicines Optimisation Regional Event, 26 th February 2019